Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Balazs Szamosfalvi"'
Autor:
H David Humes, Keith D Aaronson, Deborah A Buffington, Hani N Sabbah, Angela J Westover, Lenar T Yessayan, Balazs Szamosfalvi, Francis D Pagani
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0273138 (2023)
BackgroundInflammation has been associated with progression and complications of chronic heart failure (HF) but no effective therapy has yet been identified to treat this dysregulated immunologic state. The selective cytopheretic device (SCD) provide
Externí odkaz:
https://doaj.org/article/fe30b57e5ebe42d6b93f04af21250879
Autor:
Lenar Yessayan, Ryann Sohaney, Vidhit Puri, Benjamin Wagner, Amy Riddle, Sharon Dickinson, Lena Napolitano, Michael Heung, David Humes, Balazs Szamosfalvi
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background Regional citrate anticoagulation (RCA) for the prevention of clotting of the extracorporeal blood circuit during continuous kidney replacement therapy (CKRT) has been employed in limited fashion because of the complexity and compl
Externí odkaz:
https://doaj.org/article/28e39ead45204651b93e5640433fd108
Autor:
Lenar T. Yessayan, MD, MS, Javier A. Neyra, MD, MS, Angela J. Westover, BS, Balazs Szamosfalvi, MD, H. David Humes, MD
Publikováno v:
Critical Care Explorations, Vol 4, Iss 5, p e0694 (2022)
OBJECTIVES:. To evaluate safety and clinical outcomes of extracorporeal immunomodulation treatment with a selective cytopheretic device (SCD) in COVID-19 ICU patients with multiple organ failure. DESIGN:. Two-center, prospective, single-arm treatment
Externí odkaz:
https://doaj.org/article/bee3ca73fad841e98e6f7d1d9dc4db61
Autor:
James A Tumlin, Claude M Galphin, Ashita J Tolwani, Micah R Chan, Anitha Vijayan, Kevin Finkel, Balazs Szamosfalvi, Devasmita Dev, J Ricardo DaSilva, Brad C Astor, Alexander S Yevzlin, H David Humes, SCD Investigator Group
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0132482 (2015)
Acute kidney injury (AKI) is a highly morbid condition in critically ill patients that is associated with high mortality. Previous clinical studies have demonstrated the safety and efficacy of the Selective Cytopheretic Device (SCD) in the treatment
Externí odkaz:
https://doaj.org/article/06aeb9675da04b439aefb2ea980b9b33
Publikováno v:
Seminars in Dialysis. 34:472-479
Disorders of serum sodium concentration are common in critically ill patients who may have concomitant acute kidney injury, chronic kidney disease, or end-stage kidney disease. Many of these patients may require customized serum sodium level manageme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f7d6a73f9b1ea5b00fe1352649ee533
https://doi.org/10.1111/sdi.12983
https://doi.org/10.1111/sdi.12983
Publikováno v:
American Journal of Kidney Diseases. 78:146-150
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e03cad765dfe0d16ba76a175bfff7b67
https://doi.org/10.1053/j.ajkd.2021.01.005
https://doi.org/10.1053/j.ajkd.2021.01.005
Autor:
Michael Heung, Amy Riddle, Sharon Dickinson, Lenar Yessayan, Balazs Szamosfalvi, David Humes, Ryann Sohaney, Lena M. Napolitano, Vidhit Puri, Benjamin Wagner
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 22, Iss 1, Pp 1-12 (2021)
BMC Nephrology, Vol 22, Iss 1, Pp 1-12 (2021)
Background Regional citrate anticoagulation (RCA) for the prevention of clotting of the extracorporeal blood circuit during continuous kidney replacement therapy (CKRT) has been employed in limited fashion because of the complexity and complications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3530898d05844874ecf4703c202514ca
https://doi.org/10.1186/s12882-021-02443-6
https://doi.org/10.1186/s12882-021-02443-6
Publikováno v:
Advances in chronic kidney disease. 28(1)
Continuous kidney replacement therapy (CKRT) has improved remarkably since its first implementation as continuous arteriovenous hemofiltration in the 1970s. However, when looking at the latest generation of CKRT machines, one could argue that clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48b323426cd0bc8b2b0cc559d82d629d
https://pubmed.ncbi.nlm.nih.gov/34389135
https://pubmed.ncbi.nlm.nih.gov/34389135
Autor:
Ryann Sohaney, Lena M. Napolitano, Sharon Dickinson, Amy Riddle, Balazs Szamosfalvi, Vidhit Puri, David Humes, Benjamin Wagner, Lenar Yessayan, Michael Heung
Publikováno v:
Kidney360
BACKGROUND: Regional citrate anticoagulation (RCA) is not recommended in patients with shock or severe liver failure. We designed a protocol with personalized precalculated flow settings for patients with absent citrate metabolism that abrogates risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d1c7f130d1833438efcf1b175fdcff
https://pubmed.ncbi.nlm.nih.gov/35373034
https://pubmed.ncbi.nlm.nih.gov/35373034
Autor:
Balazs Szamosfalvi, Lenar Yessayan
Publikováno v:
Nature Reviews Nephrology
Nature Reviews. Nephrology
Nature Reviews. Nephrology
Continuous kidney replacement therapy (CKRT) can be a lifesaving intervention for critically ill patients; however, mortality remains high. The adaptation of existing innovations, including anti-clotting measures; cloud-computing for optimized treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e7111a03a9c1583da55dc39a0ded60